Stephen J. Mcandrew's most recent trade in Sonnet BioTherapeutics Holdings Inc was a trade of 6,000 Common Stock done . Disclosure was reported to the exchange on July 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sonnet BioTherapeutics | Stephen J. Mcandrew | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 6,000 | 6,446 | - | - | Common Stock |